Standard Operating Procedure
SOP-3 Determining IND Status & WI
SOP-4 Administrative Letters & WI
SOP-5 Action Letters, Parts A & B
SOP-6 OCT Audits
SOP-8 CTRP Initial Registrations
SOP-9 OnCore Subject ID Numbering
SOP-10 Subject Eligibility & WI
SOP-11 Drug Accountability & WI
SOP-12 Start Up Meetings
SOP-13 IND Safety Reporting, Parts A and B & WI
SOP-14 Research Charts
SOP-15 Adverse Events & WI
SOP-16 LCCC IND Updated FDA Form 1572 & WI
SOP-18 Study Specific Training & WI
SOP-20 Screening and Enrollment Logs & WI
SOP-21 Informed Consent & WI

Facebook
X
LinkedIn
Forward